* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Heart failure - Modest Mango
Cardiac contractility modulation wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Electrocardiography wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Heart failure wikipedia , lookup
Jatene procedure wikipedia , lookup
Coronary artery disease wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
PALi Cardiology Revision: Heart Failure Lucille Ramani [email protected] Heart Failure Definition “a complex of signs and symptoms that occurs when the heart fails to pump adequate CO” Epidemiology • Prevalence: 3-20 per 1000 • 5% emergency admissions • by 50% in the next 25 years • 50% dead by 5 years • Mainly a disease of the older population (>65 years) Aetiology Cause Cardiovascular disease Pulmonary disease Specific Examples IHD; cardiomyopathies; HTN; myocarditis; valvular heart disease; congenital heart diseases Pulmonary HTN; pulmonary valve stenosis; PE; chronic pulmonary disease; neuromuscular disease Toxins Heroin; alcohol; cocaine; amphetamines; lead; arsenic; cobalt; phosphorus Infection Bacterial; fungal; viral (HIV); Borrelia burgdorferi (Lyme disease); sepsis Electrolyte imbalance Endocrine disorders calcium, phosphate, potassium, sodium DM; thyroid disease; hypoparathyroidism; phaeochromocytoma; acromegaly Systemic collagen vascular diseases Drug-induced Nutritional deficiencies Pregnancy SLE; RA; systemic sclerosis; polyarteritis nodosa; Reiter’s syndrome Adriamycin; cyclophosphamide; sulphonamides Thiamine; selenium; L-carnitine Peripartum cardiomyopathy Right Heart Failure (RHF) • Aetiology: – Chronic pulmonary disease cor pulmonale – Left-sided heart failure – Patent ductus arteriosus – Isolated right-sided cardiomyopathy – Tricuspid valve disease • RV pressure backward failure systemic venous congestion RHF: Clinical Features • Symptoms – Fatigue – Dyspnoea – Anorexia, nausea – Nocturia • Signs – JVP – Smooth, tender hepatomegaly – Ascites – Pitting oedema (sacral, ankle) – Hypotension – Cyanosis, cool peripheries LHF: Aetiology • Ischaemic heart disease • Chronic systemic HTN • Cardiomyopathy (usually dilated) • Mitral / Aortic valve disease – Mitral regurgitation: volume overload ( preload ) – Aortic stenosis: pressure overload ( afterload) • Consequence = pulmonary congestion LHF: Clinical Features • Symptoms – Fatigue – Dyspnoea: exertional; orthopnoea; paroxysmal nocturnal – Cough ± frothy pink sputum; haemoptysis • Signs – Few, but prominent at late stage – Weight loss; muscle wasting – Cardiomegaly – Pulmonary oedema (creps) – Hypotension; cool peripheries – S3 and tachycardia: triple gallop rhythm Pathophysiology • Compensatory mechanisms become overwhelmed and thus pathological (cardiac decompensation) • Key concepts: – CO is a function of preload and afterload – Preload: end-diastolic wall stress (initial stretching of myocytes) – Afterload: the resistance against which the heart has to pump – Frank-Starling mechanism: change in SV in response to change in preload – in preload via Rx is beneficial – in workload and symptoms arising from venous congestion Compensatory Changes 1. filling pressures to maintain SV 2. Dilation: increased wall tension ischaemia 3. Hypertrophy to balance pressure overload 4. Sinus tachycardia 5. Neurohormonal mechanisms • Activation of RAAS - systemic vascular resistance - Aldosterone release (Na+ and water retention) - ADH release (water retention) • Sympathetic activity ( catecholamines) - HR, force of contraction and peripheral vasoconstriction Diagnosis Diagnosis of HF (European Society of Cardiology Guidelines) Essential Features 1. Symptoms and signs of heart failure (e.g. SOB, fatigue, ankle oedema) 2. Objective evidence of cardiac dysfunction (at rest) Non-essential Features: in cases where there is diagnostic doubt 3. Response to treatment directed towards heart failure • • • • Bloods; cardiac enzymes/markers BNP (>100pg/mL = 95% specificity and 98% sensitivity ECG Transthoracic doppler ECHO: EF<0.45 Chest X-ray Findings • Alveolar oedema (“Bat’s wings”) • Kerley B lines (interstitial oedema) • Cardiomegaly • Dilated prominent upper lobe vessels • Pleural Effusions • LV dysfunction dilation of pulmonary vessels leakage of fluid into interstitium pleural effusion alveolar oedema (pulmonary oedema) Management • Aims: – Treat cause, e.g. valve disease – Treat exacerbating factors, e.g. anaemia, HTN – Relieve S+S – Augment survival • General Measures: – Smoking cessation – Salt reduction and fluid restriction if severe – Maintenance of optimal weight and nutrition – Vaccinations: pneumoccocal (once only) and annual influenza – Assess for depression – Monitor: functional capacity, fluid status, cardiac rhythm Pharmacological Rx • Diuretics – Routinely loop diuretics, e.g. Furosemide 40mg/24h po (increase prn) – Can add spironolactone or metolazone • ACEi – Long-acting, e.g. lisinopril 10mg/24h po – Start with small dose and increase every 2 weeks until at target (30-40mg) – Warn patients of side effects: hypotension (esp after first dose- advise to lie down); dry cough; hyperkalaemia; taste disturbance – Check U+E and creatinine before starting and with each titration Pharmacological Rx • Beta-blockers – – Initiate after ACEi and diuretic Start low, go slow e.g. carvedilol 3.125mg/bd 25-50mg/bd (at least 2 week increments) • Angiotensin-II receptor antagonists – Alternative if intolerant of ACEi • Digoxin – Use if diuretics, ACEi or BB do not control symptoms or if in AF – 0.125mg-0.24mg/24h – po Monitor U+E and maintain potassium at 4-5mmol/L Acute HF • Most commonly occurs in context of acute MI extensive loss of ventricular muscle – Also: PE, cardiac tamponade, rupture of IV septum (producing VSD), AF • Clinical presentation: – Acute worsening (decompensation) of chronic HF – Acute pulmonary oedema: respiratory distress, crackles, pink frothy sputum – Cardiogenic shock: hypotension, tachycardia, oliguria • Investigations: – CXR – ECG; consider ECHO and BNP – U+E; cardiac markers; ABGs Acute HF Management • Different to chronic; Rx before Ix • Sit pt up + high-flow O2 (100% if no lung disease) • IV access and ECG (Rx any arrhythmia, e.g. AF) • Diamorphine 2.5-5mg IV slowly • Furosemide 40-80mg IV slowly • GTN spray 2 puffs sublingual then infusion of isosorbide dinitrate 2-10mg/h • If pt worsening- first get help, then: – Further dose of furosemide – Consider ventilation or increasing nitrate infusion MEQ Past Paper MEQ 1.2 Marks A 78 year old man had a large anterior myocardial infarction 3 years ago. Initially he made a good recovery although he has required to take a diuretic for ankle swelling since. In the last 2 months he has become short of breath on exertion. You suspect he has developed left ventricular failure (a) Give 2 additional symptoms which would support this diagnosis 2 (b) You arrange for a chest x-ray. Give 4 features which would support the diagnosis of left ventricular failure 4 (c) Give 2 neurohumoral mechanisms which may be activated in heart failure 1 (d) If starting this patient on an ACE Inhibitor give 3 precautions you would take 3 Further Questions • What are the possible causes for deterioration in HF? (3) • Immediate treatment of acute HF and how you would administer this? (3) Thank-you! Any Questions?